TYR and melanoma: A slightly different version of tyrosinase promoter/enhancer combination has been claimed to reach, at least in a very limited number of melanoma cells, comparable expression levels as from CMV promoter [57], whereas others found only maximal 1.3% of the CMV promoter-driven transcriptional activity [59].